Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTLI.L Regulatory News (TLI)

  • There is currently no data for TLI

Interim Management Statement - Replacement

19 Nov 2010 12:24

RNS Number : 5095W
Alternative Asset Opps PCC Ltd
19 November 2010
 



The following replaces the "Interim Management Statement" announcement released on Friday 19th November 2010 under RNS 4913W. The NAV impact of the two recent policy maturities is circa 2.4 pence. The full amended text appears below.

 

 

19 November 2010

Alternative Asset Opportunities PCC Limited

(the "Company")

Interim Management Statement

 

This interim management statement relates to the period from 1 July 2010 to the date of publication of this statement and has been prepared solely to provide additional information in order to meet the relevant requirement of the UK Listing Authority's Disclosure and Transparency Rules, and should not be relied on by Shareholders, or any other party, for any other purpose.

 

The Company is a closed-ended Guernsey protected cell company with one cell known as the US Traded Life Interests Fund (the "Fund").

 

Investment objective

The Company's investment objective in respect of the Fund is to provide investors with an attractive capital return through investment predominantly in a diversified portfolio of US Traded Life Interests ("TLIs").

 

Financial position and performance

Over the period to 30 September 2010, the Company's net asset value per share decreased by 6.3% to 77.4 pence. As at 30 September 2010, the shares were trading at a 29.5% discount to net asset value.

 

No mortalities were accounted for in the period. We have recently been notified of two policy maturities, which will be accounted for at the end of November 2010. It is estimated that these will add circa 2.4 pence to the NAV per share. There will then have been, in aggregate, 26 policy maturities since the Fund's inception.

 

The Company's loan agreement with Allied Irish Banks plc was renewed in February 2010, and this provides the Company with the ability to borrow up to US$33,156,000 until 31 January 2011. As of 30 September 2010 total borrowings under the agreement amounted to US$28,048,000.

 

The Board is not aware of any other material events during the period from 1 July 2010 to 30 September 2010, or in the period from 1 October 2010 to the date of this announcement, which would have had a material impact on the financial position of the Company.

 

Illustrative predicted yields

The tables below give a range of outcomes on differing assumptions about the portfolio. The Board will continue to analyse the information available to it to ensure valuations are soundly based.

 

31 December 2012

31 December 2016

IRR5

IRR5

IRR5

IRR5

Variation in mortality1

LE change (years) 2

Policies surviving3

Remaining Shares in issue 4

100%6

70%7

Policies surviving3

Remaining Shares in issue 4

100%6

70%7

100%

0.00

69.7%

96.0%

13.40%

-3.22%

31.9%

37.0%

9.87%

3.78%

80%

+1.20

74.7%

100.0%

8.06%

-7.78%

39.1%

61.5%

5.11%

-0.72%

50%

+4.12

83.0%

100.0%

-1.53%

-15.96%

54.1%

100.0%

-4.25%

-9.56%

30%

+8.00

89.3%

100.0%

-9.39%

-22.67%

68.0%

100.0%

-19.89%

-24.34%

 

Ignore

Medical Underwriting8

n/a

81.7%

100.0%

2.09%

-12.87%

44.4%

83.8%

3.29%

-2.44%

 

100% mortality projected from Share Price9

0.00

69.7%

100.0%

32.54%

13.11%

31.9%

37.0%

16.22%

9.77%

 

Notes

1. The base case (100%) assumes that claims experience matches the valuation basis in force at 30 September 2010. The other scenarios assume the mortality experience is worse than expected. (e.g. 110% means that if one expected 10 deaths, one instead experiences 11) or lower (e.g. 80% means that if one expected 10 deaths, but experiences 8).

2. This shows the effect of the mortality experience on the life expectancy (in years) for an otherwise normal 80-year-old non-smoker.

3. The proportion of policies surviving to the specified date based on the portfolio as at 30 September 2010. No allowance has been made for the policies that have matured after this date.

4. The model assumes that shares are repurchased whenever excess cash is available beyond that required for premium reserves. This column represents the number of shares still in issue and not repurchased at the relevant date.

5. This shows how the return varies for a shareholder holding the shares between 30 September 2010 and the relevant date (31 December 2012 or 31 December 2016) based on the growth in the NAV per share. The NAV at that date was 77.4 pence per share.

6. Return based on winding up at the relevant date assuming that the net realised proceeds of assets is 100% of the valuation calculated in accordance with the valuation basis in force at 30 September 2010.

7. Return based on winding up at the relevant date assuming that the net realised proceeds of assets is 70% of the valuation calculated in accordance with the valuation basis in force at 30 September 2010.

8. Mortality outcome assuming the lives are all "normal" lives from the point of view of mortality expectations and ignoring the implied relative health from medical underwriting. These figures are projected from the current NAV.

9. Return to investor from share price at 30 September 2010 (54.5 pence per share)

 

Source: SL Investment Management Limited

 

Top ten holdings

By reference to the most recent portfolio valuation of the Company as at 30 September 2010, the largest ten investments held by the Company, measured by life office exposure, were as follows:

 

Issuer

Number of policies

% of totalassets as at30 September 2010

American General Life Insurance Company (TX)

13

16.37%

Lincoln National Life Insurance Co

18

14.00%

Transamerica Life Insurance Company

21

13.08%

John Hancock Life Insurance Company

13

9.17%

Massachusetts Mutual Life Insurance Co

10

9.15%

Aviva Life and Annuity Company

6

6.45%

Pacific Life Insurance Company

6

5.39%

MetLife Insurance Company of Connecticut

8

4.45%

New York Life Insurance and Annuity Corp

6

3.57%

Security Life of Denver Insurance Co

1

3.24%

 

Company Information

 

Launch date 25 March 2004

EPIC TLI

Year end 30 June (from 2010 onwards)

Report & Accounts 2010 Annual Report posted October, Interim posted ?February

AGM November

Price Information Financial Times (under INVESTMENT COMPANIES, listed as 'AltAstsOpps.')

 

Investor Information

 

The latest available portfolio information included in the interim and annual report and accounts can be accessed via http://www.rcm.com/investmenttrusts/investors_tlif.php (under the Professional Investors section)

 

By order of the Board

Alternative Asset Opportunities PCC Limited

 

Enquiries:

Peter Ingram

Company Secretary Tel: 020 7065 1467

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSKKCDKBBDDCDD
Date   Source Headline
4th Dec 20133:43 pmRNSListing Rule 15.6.8
19th Nov 20134:15 pmRNSInterim Management Statement
15th Nov 20131:26 pmRNSNet Asset Value(s)
13th Nov 20132:27 pmRNSResult of AGM
8th Nov 20133:06 pmRNSHolding(s) in Company
4th Nov 20139:28 amRNSListing Rule 15.6.8
1st Nov 20134:44 pmRNSChange of Name of Investment Manager
15th Oct 201312:35 pmRNSNet Asset Value(s)
3rd Oct 20131:13 pmRNSNet Asset Value(s)
2nd Oct 20134:05 pmRNSListing Rule 15.6.8
2nd Oct 20137:00 amRNSFinal Results
3rd Sep 201310:17 amRNSListing Rule 15.6.8
19th Aug 20135:26 pmRNSHolding(s) in Company
19th Aug 20134:13 pmRNSHolding(s) in Company
19th Aug 201312:38 pmRNSHolding(s) in Company
19th Aug 20139:28 amRNSNet Asset Value(s)
2nd Aug 201310:29 amRNSListing Rule 15.6.8
26th Jul 201312:36 pmRNSPortfolio Update
15th Jul 20133:29 pmRNSNet Asset Value(s) - Replacement
15th Jul 20139:54 amRNSNet Asset Value(s)
12th Jul 201312:17 pmRNSDirector Declaration
2nd Jul 201312:02 pmRNSListing Rule 15.6.8
17th Jun 201310:31 amRNSNet Asset Value(s)
4th Jun 201311:35 amRNSListing Rule 15.6.8
16th May 201312:27 pmRNSNet Asset Value(s)
10th May 201311:04 amRNSInterim Management Statement
2nd May 201310:38 amRNSListing Rule 15.6.8
16th Apr 201311:25 amRNSNet Asset Value(s)
3rd Apr 201311:33 amRNSListing Rule 15.6.8
15th Mar 201311:36 amRNSNet Asset Value(s)
4th Mar 201310:28 amRNSListing Rule 15.6.8
28th Feb 20138:14 amRNSHalf Yearly Report
21st Feb 20138:03 amRNSDirector/PDMR Shareholding
21st Feb 20138:02 amRNSDirectorate Change
15th Feb 201312:07 pmRNSNet Asset Value(s)
7th Feb 201312:36 pmRNSDirector Declaration
4th Feb 201311:33 amRNSListing Rule 15.6.8
15th Jan 20132:45 pmRNSNet Asset Value(s)
14th Dec 20123:10 pmRNSDirector/PDMR Shareholding
14th Dec 201210:41 amRNSNet Asset Value(s)
6th Dec 20121:25 pmRNSListing Rule 15.6.8
19th Nov 20124:22 pmRNSInterim Management Statement
14th Nov 20121:15 pmRNSResult of AGM
12th Nov 20122:15 pmRNSNet Asset Value(s)
6th Nov 20124:35 pmRNSHolding(s) in Company
5th Nov 201211:12 amRNSDirector/PDMR Shareholding
5th Nov 201211:06 amRNSDirector/PDMR Shareholding
2nd Nov 201210:02 amRNSListing Rule 15.6.8
1st Nov 201212:17 pmRNSResult of EGM
26th Oct 20121:31 pmRNSResult of Placing and Open Offer

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.